版本:
中国

BRIEF-aTyr Pharma qtrly net loss per share attributable to common stockholders $0.53

March 16 aTyr Pharma Inc

* Atyr pharma -continues to expect that its cash, cash equivalents and investments will be sufficient to fund its anticipated operations into q3 of 2018

* Atyr pharma announces fourth quarter and year-end 2016 operating results

* Qtrly net loss per share attributable to common stockholders$0.53

* Q4 earnings per share view $-0.63 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐